Titan Biotech Limited announced unaudited standalone earnings results for third quarter and nine months ended Dec. 31, 2014. For the quarter, the company reported net sales/income from operations of INR 83.041 million, profit from operations before other income, finance costs & exceptional items of INR 5.993 million, profit before tax of INR 6.134 million, net profit of INR 4.05 million or INR 0.52 per basic and diluted share compared to the net sales/income from operations of INR 93.318 million, profit from operations before other income, finance costs & exceptional items of INR 6.32 million, profit before tax of INR 5.877 million, net profit of INR 3.881 million or INR 0.65 per basic and diluted share for the same quarter a year ago.

For the year to date, the company reported net sales/income from operations of INR 283.536 million, profit from operations before other income, finance costs & exceptional items of INR 21.966 million, profit before tax of INR 18.431 million, net profit of INR 12.167 million or INR 1.57 per basic and diluted share compared to the net sales/income from operations of INR 280.124 million, profit from operations before other income, finance costs & exceptional items of INR 15.315 million, profit before tax of INR 17.229 million, net profit of INR 11.373 million or INR 1.8 per basic and diluted share for the same period a year ago.